Splenic B-cell lymphoma/leukemia with prominent nucleoli (SBLPN) is a new entity in the 5th edition of the WHO classification, which contains HCLv and also cases that were previously classified as CD5 negative B-cell prolymphocytic leukemia (B-PLL) [1]. This evidence concerns the gene CD5 and B-cell prolymphocytic leukemia.